Profiling data showed that LCMR1 was mainly upregulated in tumor tissues, including NSCLC, such as lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) (Figure 1A). Here, MED19 is linked to lung adenocarcinoma.